Memoractiv

Thorne Memoractiv is a comprehensive, synergistic blend of the most widely studied supplements known to promote brain health in one memory-enhancing product. The ingredients in Thorne Memoractiv have been proven to enhance cognitive function via a variety of therapeutic mechanisms, and are provided in a convenient combination formula.

Double-blind trials of phosphatidylserine (PS) demonstrate benefits for older subjects with mild-to-moderate dementia, as well as middle-aged subjects with age-related cognitive decline. PS partially restored learning and recall capacities in this population. On name-face matching PS improved performance from a functional age of 64 to a functional age of 52. PS can benefit individuals in stressful situations. Three double-blind trials established that in young, healthy male athletes subjected to heavy exercise regimens PS reduced cortisol production while controlling muscle soreness and other aspects of overtraining.

Acetyl-L-carnitine (ALC) has been employed in the management of cognitive decline. In one double-blind trial conducted with cognitively impaired ex-alcoholics ages 30-60, 2 g ALC daily for three months improved memory, visuo-spatial capacity, and vocabulary recall. In controlled trials, ALC also improved depression, cooperation, sociability, and attention to personal appearance.

Ginkgo biloba enhances mental alertness, reaction time, memory, and cognition. Many studies have shown Ginkgo improves mental functioning in individuals with age-related memory loss and mild-to-moderate dementia. A meta-analysis evaluating six Ginkgo studies found between 17 and 71 percent of patients were benefited at average daily dosages of 160 mg Ginkgo extract (24% ginkgo heterosides).

Improved GABA levels are one of the mechanisms attributed to Bacopa monniera. An Ayurvedic herb, Bacopa is neuro-protective and has been shown to improve memory and learning. Vinpocetine enhances cerebral circulation and oxygen utilization, resulting in improved cognitive function. In double-blind trials conducted with patients suffering from mild-to-moderate vascular dementia, vinpocetine benefited memory, learning, and global clinical measures of cognitive performance. Speech and language also improved.